Amneal launches FDA-approved 120 mg generic lanreotide
Amneal Pharmaceuticals says it received FDA approval for a 120 mg generic lanreotide (Somatuline Depot) and has launched the injectable with in-house manufacturing and a CGT designation.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.